This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-estimates: Archive
California Resources Corporation (CRC) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
California Resources (CRC) delivered earnings and revenue surprises of +20.88% and +21.84%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CRCPositive Net Change GRNTPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
LifeMD, Inc. (LFMD) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
LifeMD (LFMD) delivered earnings and revenue surprises of -200.00% and -6.02%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
LFMDPositive Net Change SHCNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Teradata (TDC) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Teradata (TDC) delivered earnings and revenue surprises of +14.63% and +1.91%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
TDCPositive Net Change NTAPNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
DMC Global (BOOM) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
DMC Global (BOOM) delivered earnings and revenue surprises of +140.00% and +3.31%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
BOOMPositive Net Change LZNo Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Chegg (CHGG) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Chegg (CHGG) delivered earnings and revenue surprises of +143.48% and +3.66%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CHGGPositive Net Change BOXNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Clover Health Investments, Corp. (CLOV) Q2 Earnings Meet Estimates
by Zacks Equity Research
Clover Health Investments (CLOV) delivered earnings and revenue surprises of 0.00% and -1.01%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CLOVPositive Net Change SDGRPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Halozyme Therapeutics (HALO) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Halozyme Therapeutics (HALO) delivered earnings and revenue surprises of +25.20% and +13.84%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
HALOPositive Net Change IOVANegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
GXO Logistics (GXO) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
GXO Logistics (GXO) delivered earnings and revenue surprises of +1.79% and +6.61%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
GXOPositive Net Change FLNGPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Centrus Energy Corp. (LEU) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Centrus Energy (LEU) delivered earnings and revenue surprises of +103.85% and +13.72%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
LEUPositive Net Change CDEPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Revolve Group (RVLV) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Revolve Group (RVLV) delivered earnings and revenue surprises of +16.67% and +4.36%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
RVLVNegative Net Change GIIINegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Latham Group (SWIM) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Latham Group (SWIM) delivered earnings and revenue surprises of +7.69% and +0.66%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
SWIMNegative Net Change WMSNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Adaptive Biotechnologies (ADPT) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
Adaptive Biotechnologies (ADPT) delivered earnings and revenue surprises of +29.17% and +18.47%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ADPTPositive Net Change ACADNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Coupang, Inc. (CPNG) Q2 Earnings Miss Estimates
by Zacks Equity Research
Coupang (CPNG) delivered earnings and revenue surprises of -71.43% and +1.37%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CPNGNegative Net Change PSQHNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Gulfport Energy (GPOR) Q2 Earnings Miss Estimates
by Zacks Equity Research
Gulfport (GPOR) delivered earnings and revenue surprises of -15.71% and +33.79%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
GPORPositive Net Change CIVINegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Gossamer Bio (GOSS) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
Gossamer Bio (GOSS) delivered earnings and revenue surprises of +5.56% and +155.88%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
GOSSPositive Net Change VSTMPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
K12 (LRN) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
K12 (LRN) delivered earnings and revenue surprises of +25.14% and +3.94%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
LRNPositive Net Change LINCPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Myriad Genetics (MYGN) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Myriad (MYGN) delivered earnings and revenue surprises of +600.00% and +5.55%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
MYGNPositive Net Change ABCLPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Acadia Healthcare (ACHC) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Acadia Healthcare (ACHC) delivered earnings and revenue surprises of +16.90% and +4.01%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ACHCPositive Net Change ECORNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Astera Labs, Inc. (ALAB) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Astera Labs, Inc. (ALAB) delivered earnings and revenue surprises of +33.33% and +11.12%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ALABPositive Net Change AVPTNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
A10 Networks (ATEN) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
A10 Networks (ATEN) delivered earnings and revenue surprises of +5.00% and +4.30%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ATENNegative Net Change ONDSPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Direct Digital Holdings, Inc. (DRCT) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Direct Digital (DRCT) delivered earnings and revenue surprises of +76.04% and -18.85%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
DRCTPositive Net Change GAMBNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Elme (ELME) Q2 FFO and Revenues Beat Estimates
by Zacks Equity Research
Elme (ELME) delivered FFO and revenue surprises of +4.35% and +0.91%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ELMENegative Net Change MDVNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Crexendo (CXDO) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Crexendo (CXDO) delivered earnings and revenue surprises of +50.00% and +2.20%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CXDOPositive Net Change UPWKPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Global Medical REIT (GMRE) Q2 FFO Meet Estimates
by Zacks Equity Research
Global Medical REIT (GMRE) delivered FFO and revenue surprises of 0.00% and +6.48%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
GMRENegative Net Change RLJNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Interparfums (IPAR) Misses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Interparfums (IPAR) delivered earnings and revenue surprises of -10.00% and -2.07%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
IPARNegative Net Change ADVNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank